Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG
- PMID: 26807434
- PMCID: PMC4720147
- DOI: 10.3233/BLC-159002
Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG
References
-
- Lamm DL, et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study. J Urol. 2000;163(4):1124–1129. - PubMed
-
- Lamm D, et al. Defining progression in nonmuscle invasive bladder cancer: It is time for a new, standard definition. J Urol. 2014;191(1):20–27. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources